Fennec Pharmaceuticals Inc. (FENC) Live Share Price, Invest From India

Fennec Pharmaceuticals Inc. Stock Performance

as on August 4, 2026 at 2:15 pm IST

Day's Low
Day's High
$9.48
Day's Price Range
$9.85
$9.59
1.15%
Downside
2.71%
Upside
52 Week's Low
52 Week's High
$5.65
52-Week Price Range
$11.31
$9.59
41.08%
Downside
17.94%
Upside

Fennec Pharmaceuticals Inc. share price movements today

Previous Close: $9.57
Open: $9.71
Volume: 186.1K
Day's Low - High: $9.48 - $9.85
52 Week Low - High: $5.65 - $11.31

Fennec Pharmaceuticals Inc. Historical Returns

1 Month Return: -10.37 %
3 Month Return: + 44.21 %
1 Year Return: + 15.26 %
3 Year Return: + 19.43 %
5 Year Return: + 45.08 %

Fennec Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Fennec Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$332.4M

EPS (TTM)

0.296

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

1.4678

EBITDA

-5.5M

Revenue (TTM)

51.0M

Profit Margin

-16.42%

Return On Equity TTM

-52.68%

Fennec Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fennec Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Fennec Pharmaceuticals Inc.	BUY	$332.4M	45.08%	NA	-16.42%	NA
Revolution Medicines Inc.	BUY	$39.9B	561.77%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$121.1B	135.84%	28.33	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$78.5B	30.69%	18.87	27.87%	0.49%

Stock Returns calculator for Fennec Pharmaceuticals Inc. Stock including INR - Dollar returns

The Fennec Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Fennec Pharmaceuticals Inc. investment value today

Current value as on today

₹1,25,328

Returns

₹25,328

(+25.33%)

Returns from Fennec Pharmaceuticals Inc. Stock

₹15,264 (+15.26%)

Dollar Impact

₹10,063 (+10.06%)

Analyst Recommendation on Fennec Pharmaceuticals Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Fennec Pharmaceuticals Inc.. Average target price of $15.67

Fennec Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Fennec Pharmaceuticals Inc..

What analysts predicted

38.8%UPSIDE

Target Price

$15.67

Current Price

$9.59

Analyzed by

12 Analysts

Target

$15.67

Fennec Pharmaceuticals Inc. target price $15.67, a slight upside of 38.8% compared to current price of $9.59. According to 12 analysts rating.

Indian Investors' Interest in Fennec Pharmaceuticals Inc. Stock

Search interest for Fennec Pharmaceuticals Inc. Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 5, 2026 to August 4, 2026

Change:-55% versus previous 30 day period

Fennec Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	9	25	7	6	7	8	9	12	13	15
Gross Profit	9	24	6	5	7	8	8	11	12	14
Operating Income	-1	13	-5	-5	0	0	-2	0	-2	0
EBITDA	-1	14	-4	-4	0	0	-2	0	-4	0
Interest Expense	0	1	1	1	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	12	-5	-5	-1	-1	-3	0	-4	0
Income Tax Expense	0	0	0	-	0	-	-	-	0	-
Net Income	-2	12	-5	-5	-1	-1	-3	0	-4	0
Net Profit Margin	-27.55%	50.59%	-76.47%	-82.23%	-25.05%	-13.31%	-32.66%	-5.12%	-34.75%	1.33%

Fennec Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	0	0	1	21	47	44
Gross Profit	-	-	-	-	0	-	1	19	44	40
Operating Income	-2	-6	-10	-13	-17	-17	-22	-13	2	-6
EBITDA	0	0	0	-12	-18	-17	-22	-12	4	-7
Interest Expense	-	-	-	-	0	0	0	3	4	2
Depreciation	-	-	-	0	0	0	0	0	0	0
Income Before Tax	-2	-7	-9	-12	-18	-17	-23	-16	0	-9
Income Tax Expense	0	0	0	0	0	0	1	0	0	0
Net Income	-2	-7	-9	-12	-18	-17	-23	-16	0	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-10652.35%	-10203.53%	-1544.89%	-75.50%	-0.92%	-21.82%

Fennec Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	12	-5	-5	-1	-1	-3	0	-4	0
Operating Cash Flow	39	-8	-2	-1	-4	-3	1	-5	2
Investing Cash Flow	-	-	0	0	-	-	-	-	-
Financing Cash Flow	-1	0	0	-12	0	0	1	20	1
Change in Cash	37	-8	-2	-13	-3	-3	3	14	3

Fennec Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-9	-12	-18	-17	-23	-16	0	-10
Operating Cash Flow	-3	-7	-9	-15	-14	-18	-17	26	-12
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	27	2	0	32	4	20	6	-13	22
Change in Cash	24	-5	-9	16	-9	2	-10	13	10

Global Institutional Holdings in Fennec Pharmaceuticals Inc.

Funds	Holdings
Apis Capital Advisors, LLC	0.59%
Citadel Advisors Llc	0.44%
Northern Trust Corp	0.44%
Gendell Jeffrey L	0.24%
The Informed Momentum Company (formerly EAM Investors)	0.28%

See all

Insights on Fennec Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, FENC stock has moved up by 44.2%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 390.7% return, outperforming this stock by 375.4%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 484.6% return, outperforming this stock by 465.2%

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Organisation	Fennec Pharmaceuticals Inc.
Headquarters	68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Industry	Biotechnology
CEO	Mr. Jeffrey S. Hackman
E-voting on shares	Click here to vote

Key Management of Fennec Pharmaceuticals Inc.

Name	Title
Ms. Christiana Cioffi M.B.A.	Chief Strategy Officer
Mr. Mark Gowland	Controller
Mr. Lei Fang	President of Pharstat Inc
Mr. Jeffrey S. Hackman	CEO & Director
Mr. Robert C. Andrade	Chief Financial Officer
Dr. Pierre S. Sayad M.S., Ph.D.	Chief Medical Officer
Mr. Terry Evans	Chief Commercial Officer

FAQs

What is Fennec Pharmaceuticals Inc. share price today?

Fennec Pharmaceuticals Inc. share price today is $9.59 as on August 4, 2026 at 8:45 am IST at the close of the market. Fennec Pharmaceuticals Inc. share today touched a day high of $9.85 and a low of $9.48.

What is the 52 week high and 52 week low for Fennec Pharmaceuticals Inc. share?

Fennec Pharmaceuticals Inc. share touched a 52 week high of $11.31 on June 29, 2026 and a 52 week low of $5.65 on April 13, 2026. Fennec Pharmaceuticals Inc. stock price today i.e. August 4, 2026 at 8:45 am IST is closed at $9.59,which is 15.21% down from its 52 week high and 69.73% up from its 52 week low.

What is Fennec Pharmaceuticals Inc.'s market capitalisation today?

Fennec Pharmaceuticals Inc. market capitalisation is $0.00T as on August 4, 2026 at 8:45 am IST.

How to invest in Fennec Pharmaceuticals Inc. Stock (FENC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fennec Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fennec Pharmaceuticals Inc. Shares that will get you 0.1564 shares as per Fennec Pharmaceuticals Inc. share price of $9.59 per share as on August 4, 2026 at 8:45 am IST.

What is the minimum amount required to buy Fennec Pharmaceuticals Inc. Stock (FENC) from India?

Indian investors can start investing in Fennec Pharmaceuticals Inc. (FENC) shares with as little as ₹95.335 or $1 (as of August 4, 2026 at 3:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in Fennec Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on August 4, 2026 at 3:45 pm IST). Based on Fennec Pharmaceuticals Inc. share’s latest price of $9.59 as on August 4, 2026 at 8:45 am IST, you will get 1.0428 shares of Fennec Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Fennec Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Fennec Pharmaceuticals Inc. stock has given 45.08% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?